Resources Contact Us Home
Internalizing anti-CD74 antibodies and methods of use

Image Number 15 for United States Patent #7931903.

The present invention provides humanized, chimeric and human anti-CD74 antibodies, CD74 antibody fusion proteins, immunoconjugates, vaccines and bispecific that bind to CD74, the major histocompatibility complex (MHC) class-II invariant chain, Ii, which is useful for the treatment and diagnosis of B-cell disorders, such as B-cell malignancies, other malignancies in which the cells are reactive with CD74, and autoimmune diseases, and methods of treatment and diagnosis.

  Recently Added Patents
Method and system for determining an optimal missile intercept approach direction for correct remote sensor-to-seeker handover
Pressure roller and fixing device equipped with the same
Non-volatile flash-RAM memory with magnetic memory
Base station device and wireless communication method
Sample analyzing device
Plants and seeds of hybrid corn variety CH336383
Washing machine
  Randomly Featured Patents
Low cost electromechanical electronic simulation circuits
Method and apparatus for image forming capable of effectively eliminating color displacement by recognizing a rotational position of a rotating member with a mechanism using detection marks
Frame for spacing glass panes
Method for lithography model calibration
Mechanism for increasing awareness and sense of proximity among multiple users in a network system
Programmable video game controller
Plasma display apparatus
Aerosol chemical vapor deposition of metal oxide films
Desktop computer blade fault identification system and method